Retatrutide in Pill Form: What UK Patients Need to Know Written by Bolt Pharmacy Published on 15/7/2026 Retatrutide in pill form is not currently available — and understanding why matters for anyone researching this investigational medicine. Retatrutide is a novel ‘triple agonist’ developed by Eli Lilly, targeting the GLP-1, GIP, and glucagon receptors simultaneously. It […]
Tag Archives: Glucagon Receptor Agonist
Retatrutide Injections: UK Guide to Administration, Dosing, and Safety Written by Bolt Pharmacy Published on 15/7/2026 Retatrutide is an investigational triple hormone receptor agonist targeting GLP-1, GIP, and glucagon receptors simultaneously — a mechanism designed to support weight management and improve metabolic health. As of 2025, retatrutide has not received MHRA or EMA marketing authorisation […]